The initiative, dubbed COVAX, aims to purchase 2 billion doses by
the end of 2021 of potential COVID-19 shots from several vaccine
makers.
The EU Commission is negotiating advance purchases of COVID-19
vaccines with several drugmakers on behalf of the 27 EU states and
has said in past weeks EU governments cannot buy vaccines through
parallel procurement schemes.
"Today, the Commission is announcing a 400 million euro contribution
to COVAX for working together in purchasing future vaccines to the
benefit of low and middle income countries," European Commission
President Ursula von der Leyen said.
[to top of second column] |
The Commission added in a statement that it was ready, together with EU states,
"to put expertise and resources at work within COVAX to accelerate and scale-up
development and manufacturing of a global supply of vaccines for citizens across
the world, in poor and rich countries."
(Reporting by Francesco Guarascio; Editing by John Chalmers and Andrew Heavens)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |